Fritextsökning
Innehållstyper
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Blir utvecklingschef
Medicinteknikbolaget Pharmacolog anställer ny utvecklingschef.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Piller med nålar gör inte ont
Biologiskt läkemedel i pillerform klarar fas I.
-
De förlänger läkemedels livslängd
I samarbete med Affibody har KTH-forskarna Torbjörn Gräslund och Johan Seijsing utvecklat en ny teknik för att förlänga halveringstiden för proteinläkemedel.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
-
Våra dåliga matvanor kostar miljardbelopp
Svenskarnas dåliga matvanor kostar inte bara tusentals liv i hjärt-kärlsjukdomar varje år. Nu har forskare lyckats sätta en prislapp på de dåliga matvanorna: 53...
-
Nya fynd kring diabetes
Genom att använda experimentella tekniker har forskare vid Karolinska Institutet kunnat visa hur de så kallade deltacellerna i en del av bukspottkörteln – de La...
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Lista: Bäst betalda toppcheferna i läkemedelsvärlden
Det är kul när det går bra för andra, eller hur? Några av dem som det gått riktigt hyggligt för – åtminstone ekonomiskt – listas här på rankningen över de bäst ...
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Stärkt skydd för Alzheimerbolag
Alzinova får besked om ytterligare patentskydd på världens största läkemedelsmarknad.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Nytt namn i Symphogens ledning
Adriann Sax har utsetts till affärschef på det danska företaget.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
BREAKING